Channelchek - Looking for the next apple? This is the orchard.

ZOMDF

$0.12

(-1.6%)

FLWS

$3.04

(-2.4%)

ACCO

$2.97

(0.68%)

ARLP

$28.59

(-0.38%)

AUIAF

$0.13

(-2.17%)

AZZ

$127.79

(2.68%)

BTBT

$1.57

(1.61%)

BTM

$2.58

(-8.04%)

CVKD

$5.2

(-9.25%)

LCE:CA

$0.38

(4.11%)

COCP

$1.08

(1.89%)

CDRO

$8.6

(5.13%)

CVGI

$3.63

(-2.16%)

LODE

$3.23

(16.01%)

CMTL

$3.6

(1.41%)

CNDT

$1.23

(-2%)

CXW

$20.07

(0.65%)

CMLS

$0.01

(0%)

DRCT

$0.82

(-0.24%)

DLHC

$6.03

(1.95%)

SSP

$3.56

(3.03%)

ELDN

$2.92

(0.87%)

EVC

$3.09

(-1.28%)

EDRY

$19.7

(-1.15%)

ESEA

$63.25

(-6.97%)

FAT

$0.16

(0%)

RAIL

$8.09

(0.37%)

GDEV

$13.33

(0%)

GOVX

$1.49

(-3.25%)

GOCO

$1.77

(-10.23%)

GHM

$85.78

(1.01%)

GLDD

$16.97

(0%)

GYRE

$7.73

(0.52%)

HMENF

$1.98

(1.54%)

III

$3.92

(-0.51%)

IPOOF

$12.89

(0.02%)

KELYA

$8.86

(2.55%)

KTOS

$79.58

(2.7%)

LUCK

$8.04

(0%)

MAIA

$1.46

(1.39%)

MGROF

$0.41

(4.4%)

NTRB

$3.81

(1.6%)

OCGN

$1.96

(1.82%)

PERF

$1.67

(-0.6%)

QMCI

$0.14

(0%)

RGP

$3.66

(-1.35%)

SGA

$11.95

(-0.08%)

SHWZ

(0%)

SHIP

$12.86

(-3.67%)

SLQT

$0.62

(-2.62%)

SKYX

$1.61

(-2.42%)

SNAL

$0.57

(2.52%)

GEO

$17.45

(3.01%)

ODP

$28

(0%)

TNXP

$15.09

(-1.63%)

TSQ

$5.7

(1.52%)

TZOO

$6.38

(3.48%)

UNCY

$6.64

(3.91%)

VVX

$69.56

(1.46%)

VNCE

$2.16

(0%)

XELB

$1.54

(2.67%)

ZOMDF

$0.12

(-1.6%)

FLWS

$3.04

(-2.4%)

channelchek-in

‌

3/25/2026

Merck Bets $6.7 Billion on a Former Microcap’s CML Drug — TERN Investors Reap the Reward

Merck (NYSE: MRK) announced Tuesday it has entered into a definitive agreement to acquire Terns Pharmaceuticals (Nasdaq: TERN), a clinical-stage oncology company, for $53.00 per share in cash — representing an approximate equity value of $6.7 billion, or roughly $5.7 billion net of acquired cash. The deal carries a 31% premium to Terns’ 60-day volume-weighted average price and a 42% premium to its 90-day VWAP as of March 24, 2026.

3 min read